期刊文献+

Gab2在SHP-2酪氨酸磷酸酶激活突变所致小鼠髓系异常增殖中的作用 被引量:1

Role of Gab2 in mouse myeloid abnormal proliferation induced by SHP-2^(D61G/+) mutation
下载PDF
导出
摘要 目的:观察SHP-2信号通路中关键接头蛋白Gab2对SHP-2激活突变引发的小鼠髓系异常增殖是否具有调控作用。方法:用Gab2-/-和SHP-2D61G/+模型小鼠建立4种基因型(SHP-2+/+、Gab2-/-、SHP-2D61G/+和SHP-2D61G/+/Gab2-/-)小鼠,解剖分析其脾大小,外周血白细胞计数,流式细胞术检测外周血及骨髓髓系细胞表面标志分子Mac-1和Gr-1并计数Mac-1和Gr-1阳性髓系细胞比例,骨髓造血干/祖细胞集落形成实验检测小鼠造血干细胞或祖细胞对细胞因子反应性,Western blotting和免疫沉淀实验检测骨髓来源肥大细胞经IL-3刺激后磷酸化蛋白激酶B(p-Akt)和磷酸化胞外信号调节激酶(p-ERK)的活化水平,以及Gab2与SHP-2蛋白的结合情况。结果:敲除Gab2后显著减轻SHP-2激活突变导致的小鼠髓系增殖表型,主要表现在:脾指数减小,外周血白细胞减少,小鼠髓系来源的Mac-1和Gr-1阳性细胞比例降低。与SHP-2D61G/+小鼠相比,经IL-3刺激后,骨髓细胞的集落形成能力显著降低;骨髓来源肥大细胞内p-ERK和p-Akt表达明显下调,SHP-2D61G/+/Gab2-/-小鼠肥大细胞内无Gab2与SHP-2结合。结论:敲除Gab2可以明显减轻SHP-2D61G/+激活突变导致的小鼠髓系异常增殖,这种减轻作用可能与SHP-2无法与Gab2结合而导致下游信号途径ERK和Akt活化减弱有关。 AIM: To investigate whether Gab2, the key adapter protein in the SHP-2 signaling pathway, is in- volved in mouse myeloid abnormal proliferation induced bySHP-2^D61G/+ mutation. METHODS : Four kinds of mouse model genotyped as SHP-2^+/+, Gab2^-/-, SHP-2^D61G/+ and SHP-2^D61G/+/Gab2^-/- were generated from crossbreeding of Gab2^-/- mice and SHP-2^D61G/+ mice. The mouse spleen size was analyzed. The number of peripheral blood leukocytes was counted by cell counting and the percentage of Mac-1 or Gr-1 positive myeloid cells in the bone marrow was detected by flow cytom- etry. The proliferation ability of bone marrow hematopoietic stem/progenitor cells in response to cytokines was assayed by colony formation. The expression of p-ERK and p-Akt and the binding capacity of SHP-2 with Gab2 in the bone marrow-de- rived mast cells stimulated with IL-3 were detected by Western blotting and immunoprecipitation. RESULTS: The pheno- type of myeloproliferative disorder, such as enlarged spleen size, increased leukocyte number and high percentage of mye- loid cells, in SHP-2^D61G/+ mutant mice was found, and was dramatically improved in .SHP-2^D61G/+/Gab2^-/- double mutation mice. Furthermore, compared with SHP-2^D61G/+ mutation mice, significantly decreased colony formation ability of the bone marrow cells with IL-3 stimulation was observed in SHP-2^D61G/+/Gab2^-/- double mutation mice. A reduced phosphorylation level of ERK/Akt, and SHP-2 without binding of Gab2 were found in SHP-2^D61G/+/Gab2^-/- bone marrow-derived mast cells with IL-3 stimulation. CONCLUSION: C, ab2 knockout significantly reduces mouse myeloid abnormal proliferation in- duced by SHP-2^D61G/+ mutation. The molecular mechanism may be associated with reduced binding of SHP-2^D61G/+ under Gab2 knockout, and further weakened the activation of downstream signaling pathways of ERK and Akt.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第6期1003-1008,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30873046 No.30973424 No.81272258) 教育部博士点基金资助项目(No.200803660005) 安徽省出国留学回国人员科技项目(N0.2009-2011)
关键词 SHP-2酪氨酸磷酸酶 基因激活突变 Gab2 髓系增殖性疾病 SI-IP-2 tyrosine phosphatase Genetic gain-of-function mutation Gab2 Myeloproliferative disorders
  • 相关文献

参考文献3

二级参考文献36

  • 1Tartaglia M,Gelb B D.Noonan syndrome and related disorders:genetics and pathogenesis[J].Annu Rev Genomics Hum Genet,2005,6:45-8.
  • 2Mohi M G,Williams I R,Dearolf C R,et al.Prognostic,therapeutic and mechnistic implications of mouse model of leukemia evoked by Shp2 (PTPN11) mutations[J].Cancer Cell,2005,7(2):179-91.
  • 3Araki T,Mohi M G,Ismat F A,et al.Mouse model of Noonan syndrome reveals cell type and gene dosage-dependent effects of Ptpn11 mutation[J].Nat Med,2004,10(8):849-57.
  • 4Mohi M G,Neel B G.The role of Shp2(PTPN11)in cancer[J].Curr opin Genet Dev,2007,17(1):23-30.
  • 5Neel B G,Gu H,Pao L.The'Shp'ing news:SH2 domain-containing tyrosine phosphatase in cell signaling[J].Trends Biochem Sci,2003,28(6):284-93.
  • 6Shi Z Q,Yu D H,Park M,et al.Molecular mechanism for the Shp-2 tyrosine phosphatase fuction in promoting growth factor stimulation of Erk activity[J].Mol Cell Biol,2000,20(5):1526-36.
  • 7Deming D,Geiger P,Chen H,et al.ZM336372,a Raf-1 activator,causes suppression of proliferation in a human hepatocellular carcinoma.cell line[J].J Gastrointest Surg,2008,12(5):852-7.
  • 8Osuki M,Oshimura M,Ito H.PI3K-Akt pathway:its functions and alterations in human cancer[J].Apoptosis,2004,9(6):667-76.
  • 9Yuan L,Yu W M,Yuan Z,et al.Role of SHP-2 tyrosine phosphatase in the DNA damage-induced cell death response[J].J Biol Chem,2003,278(17):15208-16.
  • 10Nishida,K.Y,and Hirano,T.The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors[J].Cancer Sci,2003,94(12):1029-33.

共引文献31

同被引文献11

  • 1Zhou C, Shen Q, Xue J, et al. Overexpression of TFRAP inhibits cell growth and induces apoptosis in oseosarcoma cells[J]. BMB Rep, 2013, 46(2) :113-118.
  • 2Lu KH, Yang HW, Su CW, et al. Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt sig- naling pathways [ J ]. Food Chem Toxicol, 2013, 52 : 193-199.
  • 3Liu ZL, Mao JH, Peng AF, et al. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migra- tion via downregulation of the PI3K/Akt signaling pathway in vitro[J]. Mol Med Rep, 2013, 7(2) :608-612.
  • 4Enomoto A, Ping J, Takahashi M. Girdin, a novel actin- binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways [ J ]. Ann N Y Acad Sci, 2006, 1086:169-184.
  • 5Ostman A, Hellberg C, Bohmer FD, et al. Protein-tyro- sine phosphatases and cancer[ J]. Nat Rev Cancer, 2006,6(4) :307-320.
  • 6Addams SJ, Aydin T,Celebi JT. GAB2-a scaffolding pro- tein in cancer[J]. Mol Cancer Res, 2012, 10(10): 1265-1270.
  • 7Xu XL, Wang X, Chen ZL, et al. Overexpression of Gab2-associated binder 2 in human lung cancer[ J]. Int J Biol Sci ,2011,7 (5) :496-504.
  • 8Zhang B, Gu F, She C, et al. Reduction of Akt2 inhibits migration and invasion of glioma cells [ J]. Int J Cancer, 2009, 125 ( 3 ) : 585-595.
  • 9Enomoto A, Murakami H, Asai N, et al. Akt/PKB regu- lates actin organization and cell motility via Girdin/APE [J]. Dev Cell, 2005, 9(3) :389-402.
  • 10Brown LA, Kalloger SE, Miller MA, et al. Amplification of 1 1q13 in ovarian carcinoma [ J ]. Genes Chromosomes Cancer, 2008, 47(6) :481-489.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部